Steven B. Ketchum - Aug 31, 2021 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Role
Chief Scientific Officer
Signature
/s/ Michael W. Kalb, by power of attorney
Stock symbol
AMRN
Transactions as of
Aug 31, 2021
Transactions value $
-$17,324
Form type
4
Date filed
9/2/2021, 08:01 PM
Previous filing
Aug 4, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRN Ordinary Shares Options Exercise +1.53K +0.34% 454K Aug 31, 2021 Direct F1, F2, F3
transaction AMRN Ordinary Shares Options Exercise +1.53K +0.34% 455K Aug 31, 2021 Direct F1, F2, F3
transaction AMRN Ordinary Shares Options Exercise +3.05K +0.67% 458K Aug 31, 2021 Direct F1, F2, F3
transaction AMRN Ordinary Shares Tax liability -$17.3K -3.13K -0.68% $5.54 455K Aug 31, 2021 Direct F1, F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRN Restricted Stock Units Options Exercise $0 -1.53K -100% $0.00* 0 Aug 31, 2021 Ordinary Shares 1.53K $0.00 Direct F1, F2, F3, F6
transaction AMRN Restricted Stock Units Options Exercise $0 -1.53K -100% $0.00* 0 Aug 31, 2021 Ordinary Shares 1.53K $0.00 Direct F1, F2, F3, F6
transaction AMRN Restricted Stock Units Options Exercise $0 -3.05K -100% $0.00* 0 Aug 31, 2021 Ordinary Shares 3.05K $0.00 Direct F1, F2, F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 As previously reported on February 27, 2020 and March 1, 2021, on May 15, 2017, the Reporting Person was granted 220,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan, of which the performance criteria related to two tranches representing 25% of the total award each was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million and of which the performance criteria related to one tranche representing 50% of the total award was deemed achieved on February 25, 2021 pursuant to reporting of audited net product revenues for 2020 exceeding $500 million. The tranches vested ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued service of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The thirty-sixth and final vesting event occurred on August 31, 2021.
F3 Not applicable.
F4 Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F5 Please see the section titled "Remarks" below for additional information.
F6 Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

Remarks:

As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 1,412,227 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned (and reportable on a Form 4) only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.